Synopsys’ Sassine Ghazi plans $5.5M stock sale

Available on EDGAR 09/15/2026 - 04:06 PM EDT Accepted by SEC EDGAR 09/15/2026 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

SYNOPSYS, INC. (SNPS) is the issuer in a notice that Sassine E. Ghazi plans to sell shares of its common stock under Rule 144. The notice reports an intent to sell 14,604 shares, with an aggregate market value of $5,474,683.26, when shares outstanding were 191,636,646 as of September 15, 2026.

The shares are to be sold through Morgan Stanley Smith Barney LLC and are tied to a stock option exercise for cash dated September 15, 2026.

Key Figures

Shares to be sold: 14,604 shares Aggregate market value: $5,474,683.26 Shares outstanding: 191,636,646 shares +2 more

5 metrics

Shares to be sold 14,604 shares Common stock covered by the Rule 144 notice

Aggregate market value $5,474,683.26 Value of the 14,604 common shares to be sold

Shares outstanding 191,636,646 shares Synopsys common shares outstanding as of September 15, 2026

Planned sale date September 15, 2026 Date associated with the intended Rule 144 sale and reference figures

Broker Morgan Stanley Smith Barney LLC Firm through which the shares are to be sold

Key Terms

Rule 144, aggregate market value, stock option exercise, securities to be sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"14604 | 5474683.26 | 191636646 | 09/15/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

stock option exercise financial

"Common | 09/15/2026 | Stock Option Exercise | ISSUER"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

securities to be sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for SNPS disclose?

It discloses that Sassine E. Ghazi intends to sell 14,604 shares of Synopsys common stock under Rule 144, with an aggregate market value of $5,474,683.26, through Morgan Stanley Smith Barney LLC.

How many Synopsys (SNPS) shares are covered by this Rule 144 notice?

The notice covers an intended sale of 14,604 shares of Synopsys common stock. This figure is listed as the number of shares or other units to be sold under Rule 144.

What is the reported market value of the SNPS shares in this Form 144?

The filing reports an aggregate market value of $5,474,683.26 for the 14,604 Synopsys common shares covered by the planned Rule 144 sale.

How many Synopsys (SNPS) shares were outstanding as referenced in the filing?

The Form 144 references 191,636,646 shares outstanding of Synopsys common stock as of September 15, 2026; this is presented as an outstanding share count, not the amount being sold.

How were the Synopsys (SNPS) shares to be sold acquired?

The shares are linked to a stock option exercise for cash dated September 15, 2026, as indicated in the section describing the securities to be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001822289
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SYNOPSYS, INC.
SEC File Number	000-19807
Address of Issuer	675 Almanor Ave. Sunnyvale CALIFORNIA 94085
Phone	(650) 584-5000
Name of Person for Whose Account the Securities are To Be Sold	SASSINE E GHAZI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14604	5474683.26	191636646	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2026	Stock Option Exercise	ISSUER			14604	09/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sassine E. Ghazi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)